Affiliation:
1. UKRAINIAN MILITARY MEDICAL ACADEMY, KYIV, UKRAINE
Abstract
The aim: To substantiate, develop and apply in clinical practice a method for the treatment of combined acne and genitourinary infections caused by chlamydia and mycoplasmas.
Materials and methods: Acne was diagnosed clinically. Chlamydia trachomatis; Mycoplasma genitalium; Mycoplasma hominis; Ureaplasma urealyticum were identified using polymerase chain reaction. 30 patients with combined acne and urogenital chlamydia and/or mycoplasmas received sequential oral antibiotic therapy with josamycin (1500 mg daily) and gatifloxacin (400 mg daily) for 10 days each. Simultaneously with antibiotic therapy, concomitant symptomatic and topical treatment was provided.
Results: The elimination of pathogens of urogenital chlamydia and/or mycoplasmas was achieved with 29 out of 30 patients (93.3%). At the same time a complete regression of facial rash inflammatory elements was detected at 18 (60%) treated patients, while with the remaining 12 (40%) the regression was significant.
Conclusions: Antibiotic therapy was used in the treatment for both acne and urogenital chlamydia and/or mycoplasmas. An original method of complex treatment of combined acne and urogenital chlamydia and/or mycoplasmas was substantiated, developed and successfully applied. The offered method of treatment can be considered as a proof of high effectiveness both for elimination of pathogens from the genitourinary system of patients, and for complete or significant elimination of inflammatory facial rash.
Reference15 articles.
1. 1. Al’banova VI, Shishkova MV. Ugri. Patogenez. Klinika. Lecheniye. [Acne. Pathogenesis. Clinic. Treatment]. Binom Publishing House. 2012, p.112. (In Russian).
2. 2. Adaptovana klinichna nastanova z diahnostyky ta likuvannya akne: MOZ Ukrayiny [Adapted clinical guidelines for the diagnosis and treatment of acne: Ministry of Health of Ukraine]. 2013, p.111. (In Ukrainian).
3. 3. Marson JW, Baldwin HE. An overview of acne therapy, Part 1: Topical therapy, oral antibiotics, laser and light therapy, and dietary interventions. Dermatol Clin. 2019; 37(2): 183–193.
4. 4. Zaenglein AL, Pathy AL, Schlosser BJ et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016; 74: 945–73.
5. 5. Contassot E, French L. New Insights into Acne Pathogenesis: Propionibacterium Acnes Activates the Inflammasome. Journal of investigative dermatology. 2013; 134(2): 310–313.